A Phase 1/2 open-label treatment development study of MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in dyads in which one member has chronic posttraumatic stress disorder (PTSD) shows MDMA-Assisted Therapy for PTSD in couples may reduce PTSD.
The results of a MAPS-sponsored pilot study published on December 7, 2020, in the European Journal of Psychotraumatology found that MDMA-assisted therapy for PTSD in couples may reduce PTSD symptoms and improve couples’ happiness. Cognitive-Behavioral Conjoint Therapy (CBCT) for PTSD and MDMA-assisted therapy for PTSD resulted in significant reductions in PTSD symptoms and relational outcomes for couples. This initial trial included six couples with a range of baseline relationship satisfaction in which one member was diagnosed with PTSD resulting from a range of traumas including childhood physical abuse, childhood sexual abuse, and active military service. Read the press release here or visit the study webpage for more information.
